29th - 30th October 2020

4th Annual MarketsandMarkets Bioprocessing of Advanced Cellular Therapies Congress-VIRTUAL (Time Zone - BRITISH SUMMER TIME(BST))

20+
Speakers
100+
Attendees
6
Networking Hours
4+
Sessions

Devising the effective manufacturing and quality control methods of cell therapies

Regenerative therapies are proving its acceptance in potential of cell-based therapies for chronic disorders. Since our past three editions, our aim through this conference is to provide illustrative approach to recent developments in technologies of bioprocessing of cellular therapies, to process development and addressing qualitative and regulatory hurdles.

In the 4th edition of MarketsandMarkets Bioprocessing of Advanced Cellular Therapies Congress-VIRTUAL, we would be focusing on the manufacturing, process development, regulatory aspects of cell therapies and gene therapies. The special impact would be laid on, gene delivery based therapies, car-T cell-based immunotherapies, automated manufacturing, allogenic therapies, with the aspects of hurdles in supply chain management and regulatory affairs.

WHAT TO EXPECT
Key Highlights

• Stem cell transplantation for cellular aspects
• Culture technology for cell & Gene therapy applications
• Ex-vivo cell and gene therapy manufacturing
• Autologous gene therapy delivery
• Conventional Car-T cell delivery
• Allogenic Car-T cell therapy application
• Quality control in manufacturing of cell therapy
• Supply chain management for cell therapy management
• Regulatory and reimbursement issues based on GMP guidelines

Who should attend?
  • Vice Presidents
  • Directors
  • Managers
  • Heads
  • Leaders
  • Engineers
  • Scientists
  • Professors 
  • Researchers
  • Project leaders
Departments
  • Cell Culture
  • Cell Therapy
  • Upstream Processing
  • Stem Cell therapy
  • Process Development
  • Bioprocessing
  • Downstream Processing
  • Quality Control
  • Bioengineering
  • Translational Sciences
  • Scale-up/out
  • Bioprocess development
  • Quality Control
  • Biotherapeutics
  • Cell Engineering
  • Regulatory affairs
CONFERENCE AGENDA

Registrations

08:00 - 08:50

Welcome address by MarketsandMarkets

08:50 - 08:55

Opening remarks by Chairperson

08:55 - 09:00 Petter Bjorquist, CEO, Verigraft

Personalised organs that will revolutionise future medicine

09:00 - 09:30 Petter Bjorquist, CEO, Verigraft
UPSTREAM PROCESSING OF CELL & GENE THERAPIES

Bioprocessing of cells and exosomes for regenerative medicine

09:30 - 10:00 Ivan Wall, Professor of Regenerative Medicine, Cell & Gene Therapy Bioprocessing, Aston University

Solution provider for R&D for cell & gene therapy applications

10:00 - 10:15 Phillip Nold, Application Specialist, Eppendorf

Automated Cell Culture Analysis – Process Development to GMP

10:15 - 10:30 Roystein Bulman, European Applications Manager, Nova Biomedical

Morning refreshments & One to one Networking

10:30 - 11:20

Development of Combinatorial Culture Technology for cell and gene therapy applications

11:20 - 11:50 Marina Tarunina, Research Director, Plasticell Limited

Process Development, Intensification and Manufacturing Strategies for ATMPs

11:50 - 12:20 Qasim Rafiq, Associate Professor, Cell & Gene Therapy Bioprocessing, University College London

The potential of NKG2D CAR T cells as a therapy for cancer

12:20 - 12:50 David Gilham, Vice President Research & Development, Celyad

An innovative strategy for the production of clinical grade induced pluripotent stem cells

12:50 - 13:05 Janet Downie, CEO , RoslinCT

Lunch & One to one Networking

13:05 - 14:05
DOWNSTREAM PROCESSING OF CELL & GENE THERAPIES

Adoptive cell therapy for cancer using tumour infiltrating lymphocyte therapy

14:05 - 14:35 John Bridgeman, Director of Cell Therapy Research, Immetacyte Ltd

Thirty years of chondrocyte transplantation - molecular and cellular aspects

14:35 - 15:05 Anders Lindahl, Professor/Chief Physician, University of Gothenburg

Pragmatic drug development solutions for virtual and semi-virtual sponsors

15:05 - 15:20 Nick Meyers, VP Product Development, Boyd Consultants Ltd

Afternoon refreshments & One to one Networking

15:20 - 16:10

Lentiviral vectors for ex-vivo cell and gene therapy - SKYPE PRESENTATION

16:10 - 16:40 Luca Crippa, Downstream Supervisor, Molmed

Enabling Autologous CAR T manufacturing at point of care

16:40 - 17:10 Ohad Karneili, Founder & CEO, Adva Biotechnology

Closing remarks by Chairperson

17:10 - 17:15

Drinks reception & Networking

17:15 - 18:15

End of Day 1

18:15 - 18:15

Registrations

08:15 - 08:50

Welcome address by MarketsandMarkets

08:50 - 08:55

Opening remarks by Chairperson

08:55 - 09:00 Fabio D'Agostino, Venture Partner, Claris Ventures
ANALYTICS AND QUALITY CONTROL FOR CELL AND GENE THERAPY PRODUCTS

Starting materials and standards for stem cell-based therapies

09:00 - 09:30 Elsa Abranches, Acting Head, Division of Advanced Therapies Director, UK Stem Cell Bank

Digital twins and efficient manufacturing process design for cell base therapies

09:30 - 10:00 Robert Thomas, Professor of Manufacturing, Cell and Gene Therapies, Loughborough University

Engineering characterisation of DASGIP bioreactors towards the optimisation of iPSC-derived Cardiomyocyte differentiation process

10:00 - 10:30 Andrea Ducci, Associate Professor, UCL Mechanical Engineering

Morning refreshments & One to one Networking

10:30 - 11:20

Digital twins and efficient manufacturing process design for cell base therapies

11:00 - 11:30 Robert Thomas, Professor of Manufacturing, Cell and Gene Therapies, Loughborough University

To go Viral, or to go Non-Viral, that is the question for cell modification - (SKYPE PRESENTATION)

11:20 - 11:50 Stefano Baila, Director of Operations & Business Development, Anemocyte
LOGISTICS, REGULATORY & INVESTMENT

Introducing an industrial approach to manufacturing TIL

11:50 - 12:20 Ryan Guest, Director Cell Production, Immetacyte Ltd

Raw and starting material control for cell-based medicines

12:20 - 12:50 Christiane Niederlaender, Regulatory Consultant and Director, AMBR Consulting

Lunch & one to one Networking

12:50 - 13:50

Public sector development of cell and gene therapies

13:50 - 14:20 Tristan Pritchard-Meaker, , Leiden University Medical Centre

Unlocking value and investment opportunities in the cell therapy industry

14:20 - 14:50 Fabio D'Agostino, Venture Partner, Claris Ventures

Closing remarks by Chairperson

14:50 - 14:55

End of Conference

14:55 - 14:55
CONFERENCE SPEAKERS
Advisors
Petter Bjorquist

Petter Bjorquist

CEO
Verigraft

Petter Bjorquist

CEO
Verigraft
Fabio D'Agostino

Fabio D'Agostino

Venture Partner
Claris Ventures

Fabio D'Agostino

Venture Partner
Claris Ventures
Speakers
Shailendra Singh (Shelly)

Shailendra Singh (Shelly)

Chief Operating Officer
MarketsandMarkets

Shailendra Singh (Shelly)

Chief Operating Officer
MarketsandMarkets
Petter Bjorquist

Petter Bjorquist

CEO
Verigraft

Petter Bjorquist

CEO
Verigraft
Ryan Guest

Ryan Guest

Director Cell Production
Immetacyte Ltd

Ryan Guest

Director Cell Production
Immetacyte Ltd
Qasim Rafiq

Qasim Rafiq

Associate Professor, Cell & Gene Therapy Bioprocessing
University College London

Qasim Rafiq

Associate Professor, Cell & Gene Therapy Bioprocessing
University College London
John Bridgeman

John Bridgeman

Director of Cell Therapy Research
Immetacyte Ltd

John Bridgeman

Director of Cell Therapy Research
Immetacyte Ltd
Elsa Abranches

Elsa Abranches

Acting Head, Division of Advanced Therapies Director
UK Stem Cell Bank

Elsa Abranches

Acting Head, Division of Advanced Therapies Director
UK Stem Cell Bank
Luca Crippa

Luca Crippa

Downstream Supervisor
Molmed

Luca Crippa

Downstream Supervisor
Molmed
David Gilham

David Gilham

Vice President Research & Development
Celyad

David Gilham

Vice President Research & Development
Celyad
SPONSORS
Silver
example-image

Nova Biomedical

Sponsors & Exhibitors
example-image

BioIVT

Speaking Partner
example-image

Boyds

example-image

RoslinCT

Conference Partner
example-image

Formulatrix

PARTNERS
Supporting Association
MabDesign

MabDesign

RegMedNet

RegMedNet

Irish Stem Cell Foundation

Irish Stem Cell Foundation

UKSB

UKSB

Media Partners
example-image

Technology Networks

example-image

GEN

example-image

Drug Target Review

example-image

CrowdReviews.com

example-image

Medical events guide

PAST EVENT GALLERY
  • Networking-Room
  • Networking-Event
  • Networking-Exhibition-Audience
  • Networking-Exhibition
  • Discussion-Conference-Audience
  • Conference-Speaker
  • Conference-Audience-Discussion
  • Conference-Room-Audience
  • Conference-Room
  • Conference-Audience
  • High Potent Medicines Conference - Networking area
  • High Potent Medicines Conference - Exhibition Area - Booths